Literature DB >> 26935494

Differential Expression of MicroRNAs in Chronic Obstructive Pulmonary Disease.

Murat Kara1, Gamze Kirkil2, Serdar Kalemci3.   

Abstract

BACKGROUND: This study aimed to investigate the associations of miRNA with COPD patients.
OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is characterized by progressive and largely irreversible airflow limitation. COPD is one of the most common causes of death globally and it is still a serious public health problem worldwide. Pathogenesis of COPD is multifactorial including genetics and environmental factors.
MATERIAL AND METHODS: Sixty patients who were diagnosed with COPD according to GOLD guidance and 40 controls were involved in the study. This study was separated into four groups according to GOLD guidance. miR_16, miR_17, miR_29c, miR_92, miR_125, miR_126, miR_146, miR_155, miR_181, mir_122 expressions from the total miRNAs obtained were worked on by using real time-PCR method. The p-values are calculated based on a Student's t-test of the replicate 2^ (- Delta Ct) values for each gene in the control group.
RESULTS: The miRNAs expressions in normal and COPD patients were found differentially. The miR-29c (p = 0.043) and -126 (p = 0.012) were found significantly different compared to control group. When their expressions are evaluated according to stage, miR-92 expression showed down regulation stage II and no change was observed in other miRNAs. miR-29c and miR-126 expressions showed significant differences in stage III and only miR-126 expression showed significant difference in stage IV.
CONCLUSIONS: These results show that miRNA evaluations may give information about the diagnosis, staging and prognosis of the disease. In this study, we demonstrated that miR-29c and -126 are essential for the development of COPD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26935494     DOI: 10.17219/acem/28343

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  13 in total

Review 1.  Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.

Authors:  Alison J Kriegel; Melanie Gartz; Muhammad Z Afzal; Willem J de Lange; J Carter Ralphe; Jennifer L Strande
Journal:  J Cardiovasc Transl Res       Date:  2016-12-28       Impact factor: 4.132

2.  MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling.

Authors:  Melina M Musri; Núria Coll-Bonfill; Bradley A Maron; Víctor I Peinado; Rui-Sheng Wang; Jordi Altirriba; Isabel Blanco; William M Oldham; Olga Tura-Ceide; Jessica García-Lucio; Benjamin de la Cruz-Thea; Gunter Meister; Joseph Loscalzo; Joan A Barberà
Journal:  Am J Respir Cell Mol Biol       Date:  2018-10       Impact factor: 6.914

3.  Micro RNA-17-92 cluster mediates interleukin-4-suppressed IL-10 expression in B cells.

Authors:  Zhi-Qiang Liu; Gui Yang; Xiao-Rui Geng; Jiang-Qi Liu; Li-Hua Mo; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

4.  A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease.

Authors:  Yahui Shen; Lina Wang; Yunhui Wu; Yingwei Ou; Huiyu Lu; Xin Yao
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

5.  Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development.

Authors:  Andreas Keller; Tobias Fehlmann; Nicole Ludwig; Mustafa Kahraman; Thomas Laufer; Christina Backes; Claus Vogelmeier; Caroline Diener; Frank Biertz; Christian Herr; Rudolf A Jörres; Hans-Peter Lenhof; Eckart Meese; Robert Bals
Journal:  Genomics Proteomics Bioinformatics       Date:  2018-07-05       Impact factor: 7.691

Review 6.  Role of Host and Pathogen-Derived MicroRNAs in Immune Regulation During Infectious and Inflammatory Diseases.

Authors:  Kumari Chandan; Meenakshi Gupta; Maryam Sarwat
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

7.  Circulating miR-125b but not miR-125a correlates with acute exacerbations of chronic obstructive pulmonary disease and the expressions of inflammatory cytokines.

Authors:  Hong-Ling Hu; Zu-Qiong Nie; Yang Lu; Xun Yang; Cheng Song; Hao Chen; Shan Zhu; Bei-Bei Chen; Jing Huang; Shuang Geng; Su Zhao
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein.

Authors:  Ying-Jiao Long; Xiao-Peng Liu; Shan-Shan Chen; Dan-Dan Zong; Yan Chen; Ping Chen
Journal:  Respir Res       Date:  2018-01-26

9.  Peripheral leukocyte microRNAs as novel biomarkers for COPD.

Authors:  Ruiying Wang; Jianying Xu; Hu Liu; Zhiping Zhao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-06

Review 10.  Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers.

Authors:  Jafar Salimian; Hamed Mirzaei; Abdullah Moridikia; Asghar Beigi Harchegani; Amirhossein Sahebkar; Hossein Salehi
Journal:  J Res Med Sci       Date:  2018-03-27       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.